6[8]Hollenberg NK.ACE inhibitors,AT1 receptor blockers,and the kidney[J].Nephrol Dial Transplant,1997,12(3):381-383.
7[10]Tada H,Ishii H,Isogai S.Protective effect of D-alpha-tocopherol on the function of human mesangial cells exposed to high glucose concentrations[J].Metabolism,1997,46 (7):779-784.
8[11]Isaka Y,Akagi Y,Ando Y,et al.Application of gene therapy to diabetic nephropathy[J].Kidney Int,1997,52 (supp1 60):100-103.
4[3]Rajiv A.Add-on angiotensin receptor blockade with maximized ACE inhibition.Kidney Int,2001,59:2282
5[4]Karin JD,Zemin C,Alison J.Role of hyperlipidemia in progressive renal disease:focus on diabetic nephropathy.Kidney Int,1999,56(suppl71):S31
6[5]Hung CC,Jinn YG,Shyi JS,et al.Insulin and heparin suppress superoxide production in diabetic rat glomeruli stimulated with low-density lipoprotein.Kidney Int,2001,59(suppl):S124
7[6]Park YS,Gudarro C,Kim Y,et al.Lovasatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats.Am J Kidney Dis,1998,31:190
8[7]Tamotsu Y,Kazunori U,Yuichi M,et al.Mechanism of preventive effect of HMG-CoA reductase inhibitor on diabetic nephropathy.Kidney Int,1999,56(suppl71):S178
9[8]Antonio C,Anna M,Franceschina M,et al.Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy.Diabetes,2000,49:2170
10[9]Hisaya T,Hiroyuki I,Sho I,et al.Protective effect of D-α-Tocophrol on the function of human mesangial cells exposed to high glucose concentrations.Metabolism,1997,46(7):779
8Fujii M,Takemura R,Yamaguchi M,et al.Troglitazone(CS-045)ameliorates albuminuria in streptozotocin-induced diabetic rats[J].Metabolisim,1997,46(9):981-983.
9Segev Y,Landau D,Rasch R,et al.Growth horm one reeel Ytorantagonism prevents early renal changes in nonobe se diabetic mice.J Am Sec Nephrol,1999,10(11):2374-81.
